Shkreli refuses to answer questions
Media playback is unsupported on your device

Martin Shkreli refuses to answer questions in Congress

Martin Shkreli, former head of Turing Pharmaceuticals, refused to answer questions at a congressional hearing focused on the company's drug pricing policy.

He invoked his constitutional right against self-incrimination.

Congress is investigating Turing's 5,000% price increase of a drug, Daraprim, used by many Aids patients.

  • 04 Feb 2016
Go to next video: Oil prices: A pipeline in history